⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
IMCR News
Immunocore Holdings plc American Depositary Shares
Engineered T Cells Market - Global Forecast 2026-2032 | CAR-T, TCR-T, and Allogeneic Platforms Unlock 8.06% CAGR and a USD 41.99 Billion Opportunity
globenewswire.com
ALLO
AMGN
ATRA
AUTL
BB
BMY
CRSP
FATE
GILD
IMCR
REGN
PFE
SANG
TCRT
Immunocore announces first patient dosed in the Phase 1 trial of IMC-S118AI – its first tissue-specific autoimmune candidate – for patients with type 1 diabetes
globenewswire.com
IMCR
KIMMTRAK Sales Forecast and Market Size Analysis - 2034 Report Tracks Sales Rising from $238.7M (2023) to $310M (2024) as the First Approved TCR Therapy for Cancer Expands Globally
globenewswire.com
IMCR
Form 8-K
sec.gov
IMCR
Immunocore announces achievement of target enrollment in registrational TEBE-AM trial with KIMMTRAK® (tebentafusp) in previously treated advanced melanoma
globenewswire.com
IMCR
Immunocore to present at upcoming investor conferences
globenewswire.com
IMCR
The Galien Foundation Announces 2026 International Prix Galien Award Nominees
prnewswire.com
AZN
MRK
BMY
GILD
JNJ
PFE
REGN
VRTX
MED
BFLY
EW
NVCR
NVO
IMCR
More Cancer Patients Are Opting to Preserve Their Tumors
globenewswire.com
IMCR
Form 8-K
sec.gov
IMCR
Immunocore reports second quarter financial results and provides a business update
globenewswire.com
IMCR